Request Trial
shutterstock_1764329549_ben_photo
Ben Photo / Shutterstock.com
23 June 2021BiotechnologyThe C5 Group (American Conference Institute, The Canadian Institute, C5)

Conference preview: ACI breaks down Section 337 at the 13th Annual Practitioners’ Think Tank

The C5 Group—which constitutes the ACI, The Canadian Institute and C5—invites WIPR readers to the conference on July 27-28, 2021, to find out exactly how these new  developments will impact their practice and clients.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
Pfizer strikes $10.5 billion oncology deal with Chinese biotech
4 June 2026   The deal gives Pfizer access to 12 early-stage oncology programmes and marks the latest in a growing wave of high-value licensing agreements between Big Pharma and Chinese biotechs.
Biotechnology
Gilead to pay up to $5bn for antibody-drug conjugates push
8 April 2026   The acquisition of Munich-based biotech gives Gilead ownership of proprietary ADCs tech at a time when pharma and biotech companies are racing to secure next-generation cancer treatments.
Biotechnology
Closing the women's health gap offers ‘benefits for all’
7 April 2026   On World Health Day 2026, despite data trending in the right direction, systemic barriers continue to limit female inventors—and women's health is suffering.


Editor's picks

Hikma v Amarin: Six takeaways from the pivotal ruling
Americas
Hikma v Amarin: Six takeaways from the pivotal ruling
9 June 2026

Editor's picks

Americas
Hikma v Amarin: Six takeaways from the pivotal ruling
9 June 2026
Americas
UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI
14 May 2026
Americas
From the courtroom: Hikma v Amarin SCOTUS oral arguments
30 April 2026
Americas
Penile implant maker’s $17m trade secret award unravels
20 April 2026
Biotechnology
Closing the women's health gap offers ‘benefits for all’
7 April 2026
Europe
European patent offices raise fees
2 April 2026

More features

US biotech fires trade secrets suit at Chinese pharma group
Pfizer strikes $10.5 billion oncology deal with Chinese biotech
Heated LNP litigation puts Moderna and Acuitas in the spotlight
Medtech company sues over seven patents for incontinence products
10x Genomics settles suit with rival and targets DNA sequencing startup
Moderna loses key mRNA patent in European vaccine fight
Ligand buys biotech in $739m cash deal with litigation sweetener
CureVac targets Moderna with 10-patent suit over Spikevax